Ciprocort 0.3%+1% (Ophthalmic Suspension)

Indications

• Treatment of acute otitis externa in adult and pediatric patients
• Susceptible strains of Pseudomonas Aeruginosa, Staphylococcus aureus, Proteus mirabilis

Pharmacology

• Ciprofloxacin & Hydrocortisone combination
• Quinolone antibiotic
• Corticosteroid
• Kills bacteria by stopping essential protein production
• Reduces inflammation

Dosage & Administration

• Adult dose: 2-4 drops instilled thrice to four times a day
• Paediatric use in patients 2 years and older
• Safety and efficacy established in clinical trials

Interaction

• No known drug interactions

Contraindications

• Discontinue at first appearance of skin rash or hypersensitivity

Side Effects

• Rare reports of headache
• Pruritis
• Migraine
• Hyperesthesia
• Paresthesia
• Fungal dermatitis
• Cough
• Rash
• Urticaria
• Alopecia

Pregnancy & Lactation

• No adequate well-controlled studies in pregnant women
• Caution in use by pregnant women
• Better not to administer during lactation

Precautions & Warnings

• Use may result in overgrowth of non-susceptible organisms
• Culture should be obtained if infection not improved after one week of therapy

Therapeutic Class

• Aural steroid & antibiotic combined preparations

Storage Conditions

• Store in cool and dry place away from light
• Keep out of reach of children
• Shake well before each use
• Use within 30 days after first opening
• Close bottle strongly after use

Related Brands

• Cero-HC 0.3%+1% (Ophthalmic Suspension) - gaco-pharmaceuticals-ltd